Obalon Therapeutics, Inc.
OBLN · NASDAQ
12/31/2024 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7 | -$12 | -$24 | -$37 |
| Dep. & Amort. | $0 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1 | $3 | $5 |
| Change in WC | $0 | -$11 | $3 | -$30 |
| Other Non-Cash | $2 | $11 | -$6 | $33 |
| Operating Cash Flow | -$4 | -$10 | -$23 | -$29 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$9 |
| Inv. Sales/Matur. | $0 | $0 | $3 | $30 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$0 | $2 | $20 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $23 | $10 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $0 | $13 | $10 |
| Financing Cash Flow | $1 | $0 | $13 | $10 |
| Forex Effect | -$0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$4 | -$10 | -$7 | $0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5 | $14 | $21 | $21 |
| End Cash | $1 | $4 | $14 | $21 |
| Free Cash Flow | -$4 | -$11 | -$23 | -$31 |